11-19056012-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_054030.4(MRGPRX2):āc.391G>Cā(p.Val131Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_054030.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRGPRX2 | NM_054030.4 | c.391G>C | p.Val131Leu | missense_variant | 2/2 | ENST00000329773.3 | NP_473371.1 | |
MRGPRX2 | NM_001303615.2 | c.391G>C | p.Val131Leu | missense_variant | 3/3 | NP_001290544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRGPRX2 | ENST00000329773.3 | c.391G>C | p.Val131Leu | missense_variant | 2/2 | 1 | NM_054030.4 | ENSP00000333800 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251460Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135900
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461890Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727248
GnomAD4 genome AF: 0.000256 AC: 39AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.391G>C (p.V131L) alteration is located in exon 2 (coding exon 1) of the MRGPRX2 gene. This alteration results from a G to C substitution at nucleotide position 391, causing the valine (V) at amino acid position 131 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at